Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Member News
Copy The Link to the  Article
Abcuro announces pre-clinical data on new immuno-oncology target
Copy The Link to the  Article

Related or similar articles

View more News
August 8, 2018

Harbour BioMed inks $350 million deal for rights to A167

USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
Member News
June 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

The MoU was signed during the official, 40thanniversary celebration ceremony of the Shanghai-Rotterdam Sister City Relationship.
Member News
March 8, 2024

Labshares Collaborates with Mispro and Charles River Accelerator and Development Lab (CRADL) to Create New Vivarium Partnerships

Exciting news at Labshares! We've partnered with Mispro and CRADL to enhance our shared lab spaces in Boston, offering members preferred pricing for top-notch research facilities.
Labshares News